Inceptionr LLC Reduces Stake in Amgen Inc.

Biotechnology firm Amgen faces changes in major investor holdings

Mar. 12, 2026 at 10:09am

Got story updates? Submit your updates here. ›

According to a recent 13F filing, Inceptionr LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN) by 67.2% during the third quarter. The firm now owns 1,381 shares of the medical research company's stock, down from 4,210 shares previously.

Why it matters

Amgen is a major biotechnology company, and changes in its major investor holdings can signal shifts in market sentiment or investment strategies. This reduction by Inceptionr LLC may indicate broader trends in how investors are viewing Amgen's prospects.

The details

Inceptionr LLC's 13F filing shows it sold 2,829 shares of Amgen during the third quarter, reducing its total position to 1,381 shares worth approximately $390,000. The firm cited unspecified reasons for the reduction in its Amgen holdings.

  • Inceptionr LLC filed its 13F report for the third quarter of the year.

The players

Inceptionr LLC

An investment management firm that has previously held a position in Amgen Inc.

Amgen Inc.

A global biotechnology company focused on discovering, developing, manufacturing, and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

This reduction in a major investor's position in Amgen highlights the need to closely monitor changes in institutional holdings for clues about the market's sentiment towards the company. As a leading biotech firm, Amgen's performance is closely watched by investors.